Addressing risks to advance mental health research

JAMA Psychiatry

Volumn 70, Issue 12, 2013, Pages 1363-1371

  Iltis, Ana S ^a   Misra, Sahana ^b,c   Dunn, Laura B ^d   Brown, Gregory K ^e   Campbell, Amy ^f   Earll, Sarah A ^g   Glowinski, Anne ^h   Hadley, Whitney B ⁱ   Pies, Ronald ^j   Du Bois, James M ^h,k  

^a WAKE FOREST UNIVERSITY   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^g St Louis Health Department   (United States)

^h WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ SYRACUSE UNIVERSITY   (United States)

^j State University of New York Upstate Medical University: College of Medicine   (United States)

^k SAINT LOUIS UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM;

ALZHEIMER DISEASE; ARTICLE; BIPOLAR DISORDER; CHRONIC PAIN; CLINICAL DECISION MAKING; CLINICAL PROTOCOL; CLINICAL TRIAL (TOPIC); CONFIDENTIALITY; CONSULTATION; DEMENTIA; HEALTH LITERACY; HIGH RISK POPULATION; HUMAN; MAINTENANCE THERAPY; MAJOR DEPRESSION; MEDICAL LITERATURE; MEDICAL PRACTICE; MENTAL HEALTH CARE; MENTAL HEALTH RESEARCH; MILD COGNITIVE IMPAIRMENT; NATIONAL HEALTH ORGANIZATION; PATIENT SAFETY; PRIMARY MEDICAL CARE; PROBABILITY; PROGNOSIS; RISK ASSESSMENT; RISK MANAGEMENT; SCHIZOPHRENIA; SUICIDAL IDEATION; WORKING MEMORY;

EID: 84890097569     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2013.2105     Document Type: Article

References (100)

1. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication [published correction appears in Arch Gen Psychiatry. 2005;62(7): 709]. Arch Gen Psychiatry. 2005;62(6):617-627.
2. Whittington CJ, Kendall T, Fonagy P, Cottrell D, Cotgrove A, Boddington E. Selective serotonin reuptake inhibitors in childhood depression: systematic review of published vs unpublished data. Lancet. 2004;363(9418):1341-1345.
3. Jureidini JN, Doecke CJ, Mansfield PR, Haby MM, Menkes DB, Tonkin AL. Efficacy and safety of antidepressants for children and adolescents. BMJ. 2004;328(7444):879-883.
4. Appelbaum PS. Drug-free research in schizophrenia: an overview of the controversy. IRB. 1996;18(1):1-5.
5. Mello MM, Studdert DM, Brennan TA. The rise of litigation in human subjects research. Ann Intern Med. 2003;139(1):40-45.
6. Stanley B; National Advisory Council on Alcohol Abuse and Alcoholism. Interventions for suicidal patients with co-occurring alcohol use disorder. 2007. http://www.niaaa.nih.gov/about-niaaa/our-work/advisory-council/agenda- minutes/advisory-council-meeting-minutes/national-15. Accessed October 11, 2012.
7. Dunn LB, Misra S. Research ethics issues in geriatric psychiatry. Psychiatr Clin North Am. 2009;32(2):395-411.
8. Knesper DJ; American Association of Suicidology and Suicide Prevention Resource Center. Continuity of Care for Suicide Prevention and Research: Suicide Attempts and Suicide Deaths Subsequent to Discharge From the Emergency Department or Psychiatry Inpatient Unit. Newton, MA: Education Development Center; 2010.
9. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The Belmont Report: ethical principles and guidelines for the protection of human subjects of research. 1979. http://www.hhs.gov/ohrp/ humansubjects/guidance/belmont.html. Accessed September 18, 2013.
10. US Department of Health and Human Services. Title 45: Public welfare. Part 46: Protection of human subjects. http://www.hhs.gov/ohrp/humansubjects/ guidance/45cfr46.html. Accessed September 18, 2013.
11. Shah S, Whittle A, Wilfond B, Gensler G, Wendler D. How do institutional review boards apply the federal risk and benefit standards for pediatric research? JAMA. 2004;291(4):476-482.
12. Mansbach J, Acholonu U, Clark S, Camargo CA Jr. Variation in institutional review board responses to a standard, observational, pediatric research protocol. Acad Emerg Med. 2007;14(4):377-380.
13. Gong MN, Winkel G, Rhodes R, Richardson LD, Silverstein JH. Surrogate consent for research involving adults with impaired decision making: survey of institutional review board practices. Crit Care Med. 2010;38(11):2146-2154.
14. McWilliams R, Hoover-Fong J, Hamosh A, Beck S, Beaty T, Cutting G. Problematic variation in local institutional review of a multicenter genetic epidemiology study. JAMA. 2003;290(3):360-366.
15. Abbott L, Grady C. A systematic review of the empirical literature evaluating IRBs: what we know and what we still need to learn. J Empir Res Hum Res Ethics. 2011;6(1):3-19.
16. Roberts LW, Warner TD, Brody JL, Roberts B, Lauriello J, Lyketsos C. Patient and psychiatrist ratings of hypothetical schizophrenia research protocols: assessment of harm potential and factors influencing participation decisions. Am J Psychiatry. 2002;159(4):573-584.
17. Candilis PJ, Geppert CM, Fletcher KE, Lidz CW, Appelbaum PS. Willingness of subjects with thought disorder to participate in research. Schizophr Bull. 2006;32(1):159-165.
18. Dunn LB, Kim DS, Fellows IE, Palmer BW. Worth the risk? relationship of incentives to risk and benefit perceptions and willingness to participate in schizophrenia research. Schizophr Bull. 2009;35(4):730-737.
19. Roberts LW, Hammond KG, Hoop J. An inverse relationship between perceived harm and participation willingness in schizophrenia research protocols. Am J Psychiatry. 2006;163(11):2002-2004.
20. Hummer M, Holzmeister R, Kemmler G, et al. Attitudes of patients with schizophrenia toward placebo-controlled clinical trials. J Clin Psychiatry. 2003;64(3):277-281.
21. Roberts LW, Warner TD, Nguyen KP, Geppert CM, Rogers MK, Roberts BB. Schizophrenia patients' and psychiatrists' perspectives on ethical aspects of symptom re-emergence during psychopharmacological research participation. Psychopharmacology (Berl). 2003;171(1):58-67.
22. Luebbert R, Tait RC, Chibnall JT, Deshields TL. IRB member judgments of decisional capacity, coercion, and risk in medical and psychiatric studies. J Empir Res Hum Res Ethics. 2008;3(1):15-24.
23. Tait RC. Vulnerability in clinical research with patients in pain: a risk analysis. J Law Med Ethics. 2009;37(1):59-72.
24. Roberts LW, Roberts B. Psychiatric research ethics: an overview of evolving guidelines and current ethical dilemmas in the study of mental illness. Biol Psychiatry. 1999;46(8):1025-1038.
25. Berg J, Appelbaum P, Lidz C, Parker L. Informed Consent: Legal Theory and Clinical Practice. New York, NY: Oxford University Press; 2001.
26. Appelbaum PS, Grisso T, Frank E, O'Donnell S, Kupfer DJ. Competence of depressed patients for consent to research. Am J Psychiatry. 1999;156(9):1380-1384.
27. Carpenter WT Jr, Gold JM, Lahti AC, et al. Decisional capacity for informed consent in schizophrenia research. Arch Gen Psychiatry. 2000;57(6):533-538.
28. Misra S, Rosenstein D, Socherman R, Ganzini L. Bipolar mania and capacity to consent: recommendations for investigators and IRBs. IRB. 2010;32(1):7-15.
29. Moser DJ, Schultz SK, Arndt S, et al. Capacity to provide informed consent for participation in schizophrenia and HIV research. Am J Psychiatry. 2002;159(7):1201-1207.
30. Stiles PG, Poythress NG, Hall A, Falkenbach D, Williams R. Improving understanding of research consent disclosures among persons with mental illness. Psychiatr Serv. 2001;52(6):780-785.
31. Bogardus ST Jr, Holmboe E, Jekel JF. Perils, pitfalls, and possibilities in talking about medical risk. JAMA. 1999;281(11):1037-1041.
32. Dubler N. New directions in human subject research: looking beyond the academic medical center: remaining faithful to the promises given: maintaining standards in changing times. Seton Hall Law Rev. 2002;32(563):567-568.
33. Volpe RL. Patients' expressed and unexpressed needs for information for informed consent. J Clin Ethics. 2010;21(1):45-57.
34. Konald C. Informal conceptions of probability. Cogn Instr. 1989;6:59-98.
35. Yamagishi K. When a 12.86% mortality is more dangerous than 24.24%. Appl Cogn Psychol. 1997;11:495-506.
36. Tverskey A, Kahneman D. Availability: a heuristic for judging frequency and probability. Cogn Psychol. 1973;5:207-232.
37. Tversky A, Kahneman D. The framing of decisions and the psychology of choice. Science. 1981;211(4481):453-458.
38. Jasper JD, Goel R, Einarson A, Gallo M, Koren G. Effects of framing on teratogenic risk perception in pregnant women. Lancet. 2001;358(9289):1237-1238.
39. Fagerlin A, Zikmund-Fisher BJ, Ubel PA. "If I'm better than average, then I'm ok?": comparative information influences beliefs about risk and benefits. Patient Educ Couns. 2007;69(1-3):140-144.
40. Health Literacy IOM. A Prescription to End Confusion. Washington, DC: National Academies Press; 2004.
41. Kirsch I, Jungeblut A, Jenkins L, Kolstad A. Adult Literacy in America. Washington, DC: Office of Educational Research and Improvement, US Dept of Education; 1993.
42. Hochhauser M. Informed consent and patient's rights documents: a right, a rite, or a rewrite? Ethics Behav. 1999;9(1):1-20.
43. Christopher PP, Foti ME, Roy-Bujnowski K, Appelbaum PS. Consent form readability and educational levels of potential participants in mental health research. Psychiatr Serv. 2007;58(2):227-232.
44. Baker FM, Johnson JT, Velli SA, Wiley C. Congruence between education and reading levels of older persons. Psychiatr Serv. 1996;47(2):194-196.
45. Christensen RC, Grace GD. The prevalence of low literacy in an indigent psychiatric population. Psychiatr Serv. 1999;50(2):262-263.
46. Currier GW, Sitzman R, Trenton A. Literacy in the psychiatric emergency service. J Nerv Ment Dis. 2001;189(1):56-58.
47. Robinson G, Merav A. Informed consent: recall by patients tested postoperatively. Bull Am Coll Surg. 1977;62(5):7-9;30.
48. Turner P, Williams C. Informed consent: patients listen and read, but what information do they retain? N Z Med J. 2002;115(1164):U218.
49. Lloyd A, Hayes P, Bell PR, Naylor AR. The role of risk and benefit perception in informed consent for surgery. Med Decis Making. 2001;21(2):141-149.
50. Meisel A, Kuczewski M. Legal and ethical myths about informed consent. Arch Intern Med. 1996;156(22):2521-2526.
51. King NM. Defining and describing benefit appropriately in clinical trials. J Law Med Ethics. 2000;28(4):332-343.
52. Dunn LB, Lindamer LA, Palmer BW, Golshan S, Schneiderman LJ, Jeste DV. Improving understanding of research consent in middle-aged and elderly patients with psychotic disorders. Am J Geriatr Psychiatry. 2002;10(2):142-150.
53. Dunn LB, Jeste DV. Enhancing informed consent for research and treatment. Neuropsychopharmacology. 2001;24(6):595-607.
54. Jeste DV, Palmer BW, Golshan S, et al. Multimedia consent for research in people with schizophrenia and normal subjects: a randomized controlled trial. Schizophr Bull. 2009;35(4):719-729.
55. Lipkus IM, Hollands JG. The visual communication of risk. J Natl Cancer Inst Monogr. 1999;25(25):149-163.
56. Gigerenzer G, Edwards A. Simple tools for understanding risks: from innumeracy to insight. BMJ. 2003;327(7417):741-744.
57. Benatar JR, Mortimer J, Stretton M, Stewart R A H. A booklet on participants' rights to improve consent for clinical research: a randomized trial. PLoS One. 2012;7(10):e47023. doi:10.1371/journal.pone.0047023.
58. Prentice KJ, Appelbaum PS, Conley RR, Carpenter WT. Maintaining informed consent validity during lengthy research protocols. IRB. 2007;29(6):1-6.
59. Jeste DV, Palmer BW, Appelbaum PS, et al. A new brief instrument for assessing decisional capacity for clinical research. Arch Gen Psychiatry. 2007;64(8):966-974.
60. Dunn LB, Nowrangi MA, Palmer BW, Jeste DV, Saks ER. Assessing decisional capacity for clinical research or treatment: a review of instruments. Am J Psychiatry. 2006;163(8):1323-1334.
61. Anderson EE, Iltis AS. Assessing and improving research participants' understanding of risk: potential lessons from the literature on physician-patient risk communication. J Empir Res Hum Res Ethics. 2008;3(3):27-37.
62. DuBois JM. Ethics in Mental Health Research. New York, NY: Oxford University Press; 2007.
63. Jefford M, Moore R. Improvement of informed consent and the quality of consent documents. Lancet Oncol. 2008;9(5):485-493.
64. Iltis AS. Lay concepts in informed consent to biomedical research: the capacity to understand and appreciate risk. Bioethics. 2006;20(4):180-190.
65. Lidz CW, Appelbaum PS, Arnold R, et al. How closely do institutional review boards follow the Common Rule? Acad Med. 2012;87(7):969-974.
66. DuBois JM, Beskow L, Campbell J, et al. Restoring balance: a consensus statement on the protection of vulnerable research participants. Am J Public Health. 2012;102(12):2220-2225.
67. Drazen JM, Wood AJ. Don't mess with the DSMB. N Engl J Med. 2010;363(5):477-478.
68. Schneider LS, Ismail MS, Dagerman K, et al. Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer's disease trial. Schizophr Bull. 2003;29(1):57-72.
69. Stroup TS, Appelbaum PS. Evaluation of "subject advocate" procedures in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia study. Schizophr Bull. 2006;32(1):147-152.
70. Pearson JL, Stanley B, King CA, Fisher CB. Intervention research with persons at high risk for suicidality: safety and ethical considerations. J Clin Psychiatry. 2001;62(suppl 25):17-26.
71. Oquendo MA, Stanley B, Ellis SP, Mann JJ. Protection of human subjects in intervention research for suicidal behavior. Am J Psychiatry. 2004;161(9):1558-1563.
72. Bruce ML, Ten Have TR, Reynolds CF III, et al. Reducing suicidal ideation and depressive symptoms in depressed older primary care patients: a randomized controlled trial. JAMA. 2004;291(9):1081-1091.
73. Reynolds CF III, Degenholtz H, Parker LS, et al. Treatment as usual (TAU) control practices in the PROSPECT Study: managing the interaction and tension between research design and ethics. Int J Geriatr Psychiatry. 2001;16(6):602-608.
74. Brown GK, Ten Have TR, Henriques GR, Xie SX, Hollander JE, Beck AT. Cognitive therapy for the prevention of suicide attempts: a randomized controlled trial. JAMA. 2005;294(5):563-570.
75. Linehan MM, Comtois KA, Murray AM, et al. Two-year randomized controlled trial and follow-up of dialectical behavior therapy vs therapy by experts for suicidal behaviors and borderline personality disorder. Arch Gen Psychiatry. 2006;63(7):757-766.
76. Clark CC. Group Leadership Skills for Nurses and Health Professionals. New York, NY: Springer; 2009.
77. Linehan MM, Comtois KA, Ward-Ciesielski EF. Assessing and managing risk with suicidal individuals. Cogn Behav Pract. 2012;19:218-232.
78. Beskow LM, Grady C, Iltis AS, Sadler JZ, Wilfond BS. Points to consider: the research ethics consultation service and the IRB. IRB. 2009;31(6):1-9. doi:10.1371/journal.pone.0004659.
79. McCormick JB, Boyce AM, Cho MK. Biomedical scientists' perceptions of ethical and social implications: is there a role for research ethics consultation? PLoS One. 2009;4(3):e4659.
80. Emanuel EJ, Wendler D, Grady C. What makes clinical research ethical? JAMA. 2000;283(20):2701-2711.
81. Association of American Medical Colleges-Association of American Universities. Protecting Patients, Preserving Integrity, Advancing Health: Accelerating the Implementation of COI Policies in Human Subjects Research. Washington, DC: Association of American Medical Colleges-Association of American Universities; 2008.
82. Angell M. Industry-sponsored clinical research: a broken system. JAMA. 2008;300(9):1069-1071.
83. Whitaker R. Mad in America: Bad Science, Bad Medicine, and the Enduring Mistreatment of the Mentally Ill. Cambridge, Massachusetts: Perseus Publishing; 2001.
84. Health care reform for Americans with severe mental illnesses: report of the National Advisory Mental Health Council. Am J Psychiatry. 1993;150(10):1447-1465.
85. Research guidelines issued for persons with mental disorders and impaired capacity to make decisions. Psychiatr Serv. 1999;50(1):128-129.
86. Grof P, Müller-Oerlinghausen B. A critical appraisal of lithium's efficacy and effectiveness: the last 60 years. Bipolar Disord. 2009;11(suppl 2):10-19.
87. Nivoli AM, Murru A, Vieta E. Lithium: still a cornerstone in the long-term treatment in bipolar disorder? Neuropsychobiology. 2010;62(1):27-35.
88. Saunders KE, Hawton K. The role of psychopharmacology in suicide prevention. Epidemiol Psichiatr Soc. 2009;18(3):172-178.
89. Tondo L, Baldessarini RJ. Long-term lithium treatment in the prevention of suicidal behavior in bipolar disorder patients. Epidemiol Psichiatr Soc. 2009;18(3):179-183.
90. Heaton PC, Garlick CM, Tran D. Evaluating drug safety in children and adolescents with bipolar disorder. Curr Drug Saf. 2006;1(3):307-318.
91. Aziz R, Lorberg B, Tampi RR. Treatments for late-life bipolar disorder. Am J Geriatr Pharmacother. 2006;4(4):347-364.
92. Albanese MJ, Pies R. The bipolar patient with comorbid substance use disorder: recognition and management. CNS Drugs. 2004;18(9):585-596.
93. Conwell Y, Duberstein PR, Caine ED. Risk factors for suicide in later life. Biol Psychiatry. 2002;52(3):193-204.
94. Salloum IM, Thase ME. Impact of substance abuse on the course and treatment of bipolar disorder. Bipolar Disord. 2000;2(3, pt 2):269-280.
95. Gelenberg AJ, Pies R. Matching the bipolar patient and the mood stabilizer. Ann Clin Psychiatry. 2003;15 (3-4:203-216.
96. Goodwin FK, Goldstein MA. Optimizing lithium treatment in bipolar disorder: a review of the literature and clinical recommendations. J Psychiatr Pract. 2003;9(5):333-343.
97. Scott J, Tacchi MJ. A pilot study of concordance therapy for individuals with bipolar disorder who are non-adherent with lithium prophylaxis. Bipolar Disord. 2002;4(6):386-392.
98. Mitchell PB, Hadzi-Pavlovic D. Lithium treatment for bipolar disorder. Bull World Health Organ. 2000;78(4):515-517.
99. Dubois JM, Bante H, Hadley WB. Ethics in psychiatric research: a review of 25 years of NIH-funded empirical research projects. AJOB Prim Res. 2011;2(4):5-17.
100. Del Vecchio P, Blyler CR. Identifying critical outcomes and setting priorities for mental health services research. In: Wallcraft J, Scharnk B, Amerin M, eds. Handbook of Service User Involvement in Mental Health Research. New York, NY: Wiley; 2009:92-211.